Locations:
SearchAdvertisement
Updated consensus approach helps clinicians efficiently improve diagnostic accuracy
The disease is not a barrier to pregnancy, but risks from disease-modifying therapies must be managed
In search of optimal imaging biomarkers, best methods for long-term follow-up
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
$1.1M award expands follow-up to six years with focus on clinical endpoints
Mounting evidence of possible shared genetic predisposition
Biomarker promises a practical way to reduce misdiagnoses
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
A focus on biological processes should improve both research and management
Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing
Advertisement
Advertisement